Showing results (1-10 of 3,024) with videos related to

Sort By:
Pageof 303
Respiratory Medicine|September 26, 2003
Tolerance to bronchodilating effects of salmeterol in COPDJ F Donohue, S Menjoge, S Kesten
Pulmonary Pharmacology & Therapeutics|January 15, 2005
One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropiumA Anzueto, D Tashkin, S Menjoge, et al.
Pharmacoeconomics|July 15, 2004
Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD)Mitchell Friedman, Shailendra S Menjoge, Susan F Anton, et al.
Chest|March 20, 1999
Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995A E Van Andel, C Reisner, S S Menjoge, et al.
Respiratory Medicine|May 16, 2006
Tiotropium in COPD patients not previously receiving maintenance respiratory medicationsSandra G Adams, Antonio Anzueto, Dick D Briggs, et al.
Chest|March 20, 1999
Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPDM Friedman, C W Serby, S S Menjoge, et al.
Chest|April 20, 1999
The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPDP M Dorinsky, C Reisner, G T Ferguson, et al.
Chest|November 18, 2000
The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study GroupR Casaburi, D D Briggs, J F Donohue, et al.
Chest|September 1, 1996
A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthmaJ P Karpel, E N Schacter, C Fanta, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary diseaseM R Littner, J S Ilowite, D P Tashkin, et al.
Pageof 303